EA201190050A1 - Композиция кветиапина - Google Patents

Композиция кветиапина

Info

Publication number
EA201190050A1
EA201190050A1 EA201190050A EA201190050A EA201190050A1 EA 201190050 A1 EA201190050 A1 EA 201190050A1 EA 201190050 A EA201190050 A EA 201190050A EA 201190050 A EA201190050 A EA 201190050A EA 201190050 A1 EA201190050 A1 EA 201190050A1
Authority
EA
Eurasian Patent Office
Prior art keywords
kvetiapina
composition
quetiapine
salt
pharmaceutical composition
Prior art date
Application number
EA201190050A
Other languages
English (en)
Other versions
EA020477B1 (ru
Inventor
Матей Павли
Ерней Задник
Франц Врецер
Роберт Писек
Саса Баумгартнер
Рок Дреу
Одон Планинсек
Original Assignee
Крка, Товарна Здравил, Д. Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Товарна Здравил, Д. Д., Ново Место filed Critical Крка, Товарна Здравил, Д. Д., Ново Место
Publication of EA201190050A1 publication Critical patent/EA201190050A1/ru
Publication of EA020477B1 publication Critical patent/EA020477B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Фармацевтическая композиция, содержащая твердую матричную систему кветиапина или его соли и ненабухающий анионный полимер.
EA201190050A 2008-11-26 2009-11-26 Композиция кветиапина EA020477B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200800291 2008-11-26
SI200900072 2009-03-18
PCT/EP2009/008431 WO2010066342A1 (en) 2008-11-26 2009-11-26 Quetiapine composition

Publications (2)

Publication Number Publication Date
EA201190050A1 true EA201190050A1 (ru) 2012-02-28
EA020477B1 EA020477B1 (ru) 2014-11-28

Family

ID=41562690

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190050A EA020477B1 (ru) 2008-11-26 2009-11-26 Композиция кветиапина

Country Status (3)

Country Link
EP (1) EP2355804A1 (ru)
EA (1) EA020477B1 (ru)
WO (1) WO2010066342A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2262486T1 (sl) 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Sestavek kvetiapina
WO2013074048A2 (en) * 2011-08-08 2013-05-23 Mahmut Bilgic Tablet forms comprising quetiapine fumarate
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
EP2822541B1 (en) * 2012-09-10 2018-08-29 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
CN111836618A (zh) * 2018-02-08 2020-10-27 景凱生物科技股份有限公司 类阿片受体拮抗剂的固体剂型用的医药剂型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
WO2005041935A1 (en) * 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
US20080268043A1 (en) * 2005-01-26 2008-10-30 Elan Pharma International Limited Controlled Release Compositions Comprising an Antipsychotic Agent
US20100056493A1 (en) * 2007-01-25 2010-03-04 Rajesh Jain Modified release pharmaceutical composition and a process of making the same
CN101091700B (zh) * 2007-07-03 2011-06-08 上海现代药物制剂工程研究中心有限公司 富马酸喹硫平缓控释制剂组合物及其制备用途
US20110052648A1 (en) * 2008-03-12 2011-03-03 Avi Avramoff Oral modified-release formulations containing thiazepines

Also Published As

Publication number Publication date
EP2355804A1 (en) 2011-08-17
EA020477B1 (ru) 2014-11-28
WO2010066342A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
UA110199C2 (en) Solid rifaximin dispersion
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
TW200740799A (en) Alpha2C adrenoreceptor agonists
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
FR2883179B1 (fr) Comprime enrobe
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0810646A2 (pt) " compostos farmacêuticos ".
BRPI0909084A2 (pt) Composição líquida, e, composto de peptídeo.
CL2007003341A1 (es) Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
EA201100084A1 (ru) Сшиваемая полимерная композиция
EA200901653A1 (ru) ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
BRPI1009823A2 (pt) "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
NO20084850L (no) MGLUR5 modulatorer I
ECSP099776A (es) Moduladores de la gamma secretasa
BRPI0908208A2 (pt) Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BRPI0811893A2 (pt) Composição de borracha acrílica e borracha vulcanizada da mesma, e suas aplicações.
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
EA201290888A1 (ru) Фармацевтическая композиция, содержащая производное пиримидинона
BRPI0720153A8 (pt) Composições e artigos que contêm uma matriz de polímero reticulada e um líquido ativo imobilizado assim como processos de utilização dos mesmos
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
CL2007002890A1 (es) Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad.
ECSP11011001A (es) Composición farmacéutica sólida

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU